A combination of chemotherapy and immunotherapy for the first time shows superiority over chemotherapy alone in metastatic bladder cancer Published on 08/10/2019 Dr. Enrique Grande, head of the Medical Oncology Service at MD Anderson Madrid, is co-chair of the IMvigor130 clinical trial, which has evaluated the efficacy of this combination in front line treatment
One in three patients on immunotherapy treatment has adverse effects involving the digestive system Published on 16/09/2019 MD Anderson Cancer Center Madrid experts advise the inclusion of specific recommendations at the nutritional level in these patients to avoid malnutrition, according to the conclusions of their research in more than 300 subjects